MARKET

RMD

RMD

Resmed
NYSE
183.78
-0.44
-0.24%
After Hours: 182.90 -0.88 -0.48% 17:27 04/24 EDT
OPEN
185.88
PREV CLOSE
184.22
HIGH
186.88
LOW
183.02
VOLUME
973.42K
TURNOVER
0
52 WEEK HIGH
243.52
52 WEEK LOW
131.49
MARKET CAP
27.03B
P/E (TTM)
30.45
1D
5D
1M
3M
1Y
5Y
ResMed Q3 2024 Earnings Preview
Seeking Alpha · 16h ago
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
NASDAQ · 19h ago
Weekly Report: what happened at RMD last week (0415-0419)?
Weekly Report · 3d ago
ResMed Keeps Bull Amid Weight-Loss Drug Trials -- Market Talk
Jarden's analysts say Eli Lilly's weight-loss drug trial results were largely as anticipated. ResMed's CPAP machines remain the gold-standard for sleep apnea treatment, analysts say. Jarden keeps an overweight rating on ResMed and its Australia-listed securities.
Dow Jones · 6d ago
ResMed's 3Q Profit to Beat Market Expectations -- Market Talk
ResMed's 3Q profit is likely to beat market expectations, Macquarie analysts say. They anticipate a March-quarter net profit of US$292 million on revenue of US $1.19 billion. Shares are up 1.8% at A$28.13.
Dow Jones · 6d ago
*ResMed Target Price Raised 2.5% to A$34.30/Share by Macquarie>RMD.AU
Dow Jones · 6d ago
RMD June 21st Options Begin Trading
NASDAQ · 6d ago
ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
ResMed Inc. (NYSE:RMD) has a 28.7x price-to-earnings ratio. The company has a strong earnings growth rate compared to most other companies in its industry. Its P/E ratio is higher than the average for the U.S. Stock market. ResMed is expected to grow its earnings by 16% over the next three years.
Simply Wall St · 04/18 10:51
More
About RMD
ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.

Webull offers Resmed Inc stock information, including NYSE: RMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RMD stock methods without spending real money on the virtual paper trading platform.